Log in
Enquire now
‌

US Patent 10335472 Therapeutic cancer vaccine

Patent 10335472 was granted and assigned to Cadila Pharmaceuticals on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Cadila Pharmaceuticals
Cadila Pharmaceuticals
Current Assignee
Cadila Pharmaceuticals
Cadila Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10335472
Date of Patent
July 2, 2019
Patent Application Number
15410842
Date Filed
January 20, 2017
Patent Citations Received
‌
US Patent 11369668 Tumor cell vaccines
‌
US Patent 11684659 Tumor cell vaccines
0
Patent Primary Examiner
‌
Stephen L. Rawlings
Patent abstract

The present invention relates to vaccine(s) comprising cancer cells expressing antigen(s), excipients, optionally adjuvant wherein the said antigen(s) is expressed on contacting the said cancer cell with p38 inducer, for use in treatment of Cancer. The vaccine composition induces specific immune response against homologous and heterologus cancer cells of the tissue/organ. The invention also provides method of preparing the same.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10335472 Therapeutic cancer vaccine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.